In 1993, the U.S. Supreme Court in Daubert v. Merrell Dow Pharmaceuticals, Inc., laid out a new test for federal trial judges to use when determining the admissibility of expert testimony. In Daubert, the Court ruled that judges should act as gatekeepers, assessing the reliability of the scientific methodology and reasoning that supports expert testimony. The resulting judicial screening of expert testimony has been particularly consequential. While the Supreme Court sought to bring better science into the courtroom, questions remain about whether the lower courts' application of Daubert accords with scientific practices. This report summarizes discussions held by an ad hoc committee of the The National Academies to consider the impact of Daubert and subsequent Supreme Court opinions and to identify questions for future study.
Titel
Discussion of the Committee on Daubert Standards
Untertitel
Summary of Meetings
Autor
Editor
EAN
9780309662499
Format
E-Book (pdf)
Hersteller
Genre
Veröffentlichung
19.07.2006
Digitaler Kopierschutz
Adobe-DRM
Anzahl Seiten
46
Unerwartete Verzögerung
Ups, ein Fehler ist aufgetreten. Bitte versuchen Sie es später noch einmal.